340B Health

340B Insight Podcast

340B Insight

340B Insight is 340B Health’s podcast, providing our members and supporters with timely news updates and discussion around the 340B drug pricing program. The podcast enables listeners to stay current and expand their knowledge of 340B to help them serve their patients and communities and remain compliant with rules and requirements. New episodes are published twice per month and include news update segments and in-depth interviews with leading experts including health care practitioners, policy and legal experts, public policymakers, and our expert staff.

Listen and Subscribe

Have a question or suggestion for 340B Insight? Email us at: podcast@340bhealth.org

Follow 340B Health on Twitter, Facebook, and LinkedIn

 

Episodes

  • Episode 19: 340B Hospitals Are COVID Vaccine Leaders


    This week we are joined by Scott Milner, senior director of pharmacy, business development, purchasing, 340B, and infusion services at St. Luke’s Health System in Idaho. Scott shares his personal experiences on how the health system has been finding ways to overcome COVID-19 vaccine distribution challenges and describes how the effort has become a personal mission for him. Prior to the interview, we discuss in our news update segment how drug companies are suing HHS in response to the department’s advisory opinion on 340B contract pharmacies. When we recorded the episode, three companies had filed such lawsuits. Since then, a fourth company also has gone to court over the issue. (Transcript)

    Read more

    This Episode is Sponsored By

  • Episode 18: Preparing for HRSA Audits


    This week we are joined by Steven Miller, vice president of pharmacy services at 340B Health. Steve discusses Health Resources & Services Administration (HRSA) audits of 340B hospitals and shares practical advice for how hospitals can best prepare, including the resources that are available to them. Prior to the interview, we provide a major news update you might have missed during the holiday season on the ongoing 340B contract pharmacy issue. (Transcript)

    Read more

    This Episode is Sponsored By

  • Episode 17: Maureen Testoni Recaps 340B for 2020


    In our final episode of 2020, we are joined by Maureen Testoni, the president and CEO of 340B Health. Our episode follows up last week’s bonus episode on 340B Health’s recent joint lawsuit against the Department of Health and Human Services regarding drug manufacturers’ refusals to provide 340B discounts when drugs are dispensed at community-based contract pharmacies. Maureen provides additional analysis on the issue and discusses her concerns with how some drug companies are attempting to change 340B into a rebate program. She also discusses the role 340B has played in helping hospitals respond to the COVID-19 pandemic this year. (Transcript)

    Read more

    This Episode is Sponsored By

  • BONUS EPISODE: Taking the 340B Case to Court


    This week we have a breaking news bonus episode of 340B Insight. 340B Health President and CEO Maureen Testoni joins us to discuss the filing of a lawsuit against the Department of Health & Human Services with four other national hospital organizations, a national pharmacists' organization, and three individual 340B hospitals, seeking to halt drug companies’ refusals to provide 340B discounts to hospitals on covered drugs dispensed at community-based contract pharmacies. (Transcript)

    Read more

  • Episode 15: Responding to COVID-19’s Resurgence


    This week we are joined by Danielle Sestito, system director for the 340B program at Northwell Health in New York. Northwell Health is New York’s largest health system and was one of the systems most affected by the initial COVID-19 outbreak last spring. Danielle shares how Northwell responded to the initial outbreak and how it has prepared for a resurgence. She also discusses how the health system has avoided drug shortages while maintaining 340B compliance and the importance of HRSA’s 340B regulatory flexibilities during the public health emergency. Prior to the interview, we share updates on how some of the Trump administration’s final health care actions could affect 340B. (Transcript)

    Read more

    This Episode is Sponsored By

  • The Biden Administration, New Congress, and 340B


    This week, we speak with Rodney Whitlock, former legislative staffer for Republicans on Capitol Hill and Jeremy Sharp, a former Capitol Hill and executive branch staffer for Democrats. Rodney and Jeremy discuss with 340B Health’s Kathryn DiBitetto how the incoming Biden administration and new Congress might affect the 340B program. The conversation also discusses what the congressional lame-duck session before the end of the year will mean for 340B and how hospital advocates should be preparing for the new administration and new Congress. Prior to the interview, we share news updates, including a bipartisan House of Representatives letter to HHS Secretary Alex Azar regarding pharmaceutical company attempts to turn 340B into a rebate program. (Transcript)

    Read more

    This Episode is Sponsored By